Hyperbaric oxygen therapy for severe acute pancreatitis. | Canada Hyperbarics Skip to main content
Clinical Study Journal of gastroenterology and hepatology 2007

Hyperbaric oxygen therapy for severe acute pancreatitis.

Christophi C, Millar I, Nikfarjam M, Muralidharan V, Malcontenti-Wilson C — Journal of gastroenterology and hepatology, 2007

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers documented a case of a 56-year-old woman with severe acute pancreatitis treated with hyperbaric oxygen therapy.

What They Found

The patient, initially presenting with an APACHE II score of 11 and a CTSI score of 9, received 100% oxygen at 2.5 atmospheres for 90 minutes, twice daily for 5 days. The therapy was well tolerated, and improvements were observed in both APACHE II and CTSI grading scores.

What This Means for Canadian Patients

While this single case suggests hyperbaric oxygen therapy might be safe and potentially beneficial for severe acute pancreatitis, it is not yet a standard treatment. Canadian patients should discuss all treatment options with their healthcare providers, as more research is needed before widespread adoption.

Canadian Relevance

This study has no direct Canadian connection as it was not conducted in Canada, nor did it involve Canadian researchers or patients.

Study Limitations

The main limitation of this study is that it is a single case report, which prevents generalization of its findings to a broader patient population.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Infection
Source Pubmed
PubMed ID 17914992
Year Published 2007
Journal Journal of gastroenterology and hepatology
MeSH Terms APACHE; Acute Disease; Female; Humans; Hyperbaric Oxygenation; Middle Aged; Pancreatitis; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.